Surprise As UK Notified Bodies Lose Major Part Of Their UK Role In Devices From March 29
Surprise As UK Notified Bodies Lose Major Part Of Their UK Role In Devices From March 29
$131.00
UK notified bodies would have had their conformity assessment roles temporarily withdrawn in the event of a no-deal Brexit in March. Learn what this move would have meant to UK start-ups. Read the MHRA response to a Medtech Insight inquiry about the role of UK notified bodies after Brexit.
Author: Amanda Maxwell
Publisher: Medtech
- Description
UK notified bodies would have had their conformity assessment roles temporarily withdrawn in the event of a no-deal Brexit in March. Discover the implications for companies with devices that needed notifiedbody assessment before getting their CE mark. Learn what this move would have meant to UK start-ups and small companies. Find out how this decision runs directly counter to the goal of pro-Brexit policymakers. Read the MHRA response to a Medtech Insight inquiry about the role of UK notified bodies after Brexit. How would MHRA support the continuity of supply of products to the UK market?
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Never Mind Next-Gen UV Filters; Existing Sunscreen Ingredients’ GRASE Status... 
Sign up to the